D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 77,600
-1,100 (-1.40%)
Apr 29, 2026, 2:00 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.45 trillion as of April 28, 2026. Its market cap has increased by 607.62% in one year.
Market Cap
3.45T
Enterprise Value
3.42T
Revenue
4.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
77,600.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.45T, an increase of 808.26%. That is a compound annual growth rate of 203.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3,447.39B | -13.74% |
| Dec 30, 2025 | 3,996.55B | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK bioscience | 3,475.63B |
| OliX Pharmaceuticals | 3,700.80B |
| PharmaResearch | 3,355.86B |
| Hugel | 2,883.94B |
| Voronoi | 5,516.62B |
| Peptron | 6,493.88B |
| Orum Therapeutics | 1,789.89B |
| LigaChem Biosciences | 7,287.91B |